Please try another search
The Medical Instruments stock earnings are likely to grow on rapid innovation and strong R&D focus in the fourth quarter. Further, rampant M&As and the modernization of 510 (k)-clearance...
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With...
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their...
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With...
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With...
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always...
As of late, it has definitely been a great time to be an investor in Meritor, Inc. (NYSE:MTOR) . The stock has moved higher by 21.2% in the past month, while it is also above its 20 Day SMA too. This...
Lumentum (LITE) came out with quarterly earnings of $1.15 per share, missing the Zacks Consensus Estimate of $1.18 per share. This compares to earnings of $1.67 per share a year ago. These figures are...
Lennox International (LII) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of $1.92 per share. This compares to earnings of $1.68 per share a year ago. These...
Hubbell (HUBB) came out with quarterly earnings of $1.72 per share, beating the Zacks Consensus Estimate of $1.69 per share. This compares to earnings of $1.54 per share a year ago. These figures are...
As of late, it has definitely been a great time to be an investor in New York Community Bancorp, Inc. (NYSE:NYCB) . The stock has moved higher by 19.8% in the past month, while it is also above its...
Roche Holding (SIX:ROG) AG (OTC:RHHBY) announced that it has completed the submission of a supplemental Biologics License Application (sBLA) to the FDA to expand the label of its breast cancer drug...